Status:
RECRUITING
Identifying Genetic Targets in Gynecological Tumors
Lead Sponsor:
Azienda USL Reggio Emilia - IRCCS
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
This observational study aims to identfy genetic targets involved in the pathogenesis of gynecological tumors, with a focus on high-grade serous ovarian carcinoma. Using a triple approach - in silico,...
Detailed Description
Ovarian cancer is the leading cause of death among gynecological malignanciens. High-grade serous ovarian carcinoma (HGSOC) represents the most common and aggressive subtype. Growing evidence suggests...
Eligibility Criteria
Inclusion
- Adult women ≥18 years old
- Histologically confirmed diagnosis of epithelial ovarian cancer (including high- grade serous, endometrioid, mucinous, clear cell, or mesonephric-like histotypes)
- Signed informed consent (for prospective cases) or ethically approved waiver (for retrospective samples)
Exclusion
- Refusal to sign informed consent
- Diagnosis of low-grade or non-epithelial ovarian tumors
- Patients whose clinical or pathological data are unavailable or insufficient for study inclusion
Key Trial Info
Start Date :
November 17 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2027
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT07169396
Start Date
November 17 2021
End Date
November 1 2027
Last Update
September 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda USL IRCCS di Reggio Emilia
Reggio Emilia, Italy